$166.01
1.28[0.78%]
At close: Apr 19
$166.01
0[0.00%]
After Hours: 4:01PM EDT
Insulet
(NASDAQ:PODD)Latest News for Insulet Stock (NASDAQ:PODD)
Insulet Stock (NASDAQ: PODD)
Categories: All
Wednesday, March 20, 2024
Friday, March 08, 2024
Tuesday, March 05, 2024
Thursday, February 29, 2024
Monday, February 26, 2024
- On Thursday February 22, Insulet Gave Q1 2024 Revenue Growth Guidance Of 17%-20%; For FY24, The Company Expects Revenue Growth In The Range Of 12%-17%Benzinga Newsdesk - Feb 26, 2024, 3:20PM
- Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On MondayAvi Kapoor - Feb 26, 2024, 11:18AM
- Insulet shares are trading lower after Barclays maintained an Equal-Weight rating on the stock and lowered its price target from $214 to $213.Benzinga Newsdesk - Feb 26, 2024, 10:13AM
- Barclays Maintains Equal-Weight on Insulet, Lowers Price Target to $213Benzinga Newsdesk - Feb 26, 2024, 7:06AM
Friday, February 23, 2024
- JP Morgan Maintains Overweight on Insulet, Raises Price Target to $225Benzinga Newsdesk - Feb 23, 2024, 3:48PM
- Analyst Scoreboard: 5 Ratings For InsuletBenzinga Insights - Feb 23, 2024, 2:00PM
- Insulet shares are trading lower after the company reported Q4 financial results.Benzinga Newsdesk - Feb 23, 2024, 8:33AM
- Nasdaq, S&P 500 Set for Mixed Open After Nvidia Euphoria: Analyst Picks Major Market Catalyst This Year If There Are No Rate CutsShanthi Rexaline - Feb 23, 2024, 7:34AM
Thursday, February 22, 2024
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Feb 22, 2024, 4:31PM
- Insulet shares are trading lower after the company reported Q4 financial results.Benzinga Newsdesk - Feb 22, 2024, 4:26PM
- Insulet: Q4 Earnings InsightsBenzinga Insights - Feb 22, 2024, 4:15PM
- Insulet Q4 2023 Adj EPS $1.40 Beats $0.66 Estimate, Sales $509.80M Beat $461.05M EstimateBenzinga Newsdesk - Feb 22, 2024, 4:09PM
- Nasdaq, S&P 500 Futures Jump As Nvidia Surge Raises 'FOMO' Rally Hopes: Analyst Tells Why Jobs Data Holds Key For MomentumShanthi Rexaline - Feb 22, 2024, 7:22AM
- Earnings Scheduled For February 22, 2024Benzinga Insights - Feb 22, 2024, 5:27AM
Thursday, February 08, 2024
Monday, February 05, 2024
Monday, January 22, 2024
Thursday, December 21, 2023
- Insulet shares are trading higher after Baird upgraded the stock from Neutral to Outperform and raised its price target from $180 to $238.Benzinga Newsdesk - Dec 21, 2023, 11:05AM
- Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For ThursdayAvi Kapoor - Dec 21, 2023, 7:36AM
- Expert Ratings For InsuletBenzinga Insights - Dec 21, 2023, 7:00AM
- Baird Upgrades Insulet to Outperform, Raises Price Target to $238Benzinga Newsdesk - Dec 21, 2023, 5:15AM
Friday, December 15, 2023
Monday, December 04, 2023
Wednesday, November 15, 2023
Monday, November 13, 2023
- Stocks Pause Ahead Of CPI Report; Commodities, Tesla, Boeing Surge On Rising China Hopes: What's Driving Markets Monday?Shanthi Rexaline - Nov 13, 2023, 1:35PM
- Shares of medical device and diabetes care stocks are trading higher in reaction to the presentation of SELECT data by Novo Nordisk. Raymond James said it did not believe there were any major surprises and the data could be seen as 'modestly de-risking.'Benzinga Newsdesk - Nov 13, 2023, 11:38AM
Friday, November 10, 2023
Tuesday, November 07, 2023
Saturday, November 04, 2023
Friday, November 03, 2023
- Piper Sandler Maintains Overweight on Insulet, Lowers Price Target to $250Benzinga Newsdesk - Nov 3, 2023, 4:32PM
- Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On FridayLisa Levin - Nov 3, 2023, 11:30AM
- Omnipod Insulin Pump Working Well For Insulet, Lifts Annual ForecastVandana Singh - Nov 3, 2023, 9:57AM
- Insulet shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 guidance.Benzinga Newsdesk - Nov 3, 2023, 9:21AM
Thursday, November 02, 2023
- Insulet shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 guidance.Benzinga Newsdesk - Nov 2, 2023, 5:06PM
- Insulet Sees Q4 Revenue Growth Of 22% To 25%; FY23 Revenue Raising Its Expected Revenue Growth To A Range Of 26% To 27%Benzinga Newsdesk - Nov 2, 2023, 4:03PM
- Insulet Q3 EPS $0.71 Beats $0.40 Estimate, Sales $432.70M Beat $414.22M EstimateBenzinga Newsdesk - Nov 2, 2023, 4:02PM
- Earnings Scheduled For November 2, 2023Benzinga Insights - Nov 2, 2023, 4:56AM